Eli Lilly Executive Who Oversaw Development of Blockbuster Diabetes Drug Is Set to Retire
The Eli Lilly & Co. executive who oversaw development of Mounjaro, its blockbuster diabetes medicine that’s also used for weight loss, will retire at the end of the year.